Mania - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulation of neurotransmitters, particularly increased dopamine and norepinephrine activity, leads to heightened arousal and mood elevation, contributing to the hallmark symptoms of mania such as hyperactivity, impulsivity, and euphoria.

• Secondary mechanism: Disrupted circadian rhythms, often involving the suprachiasmatic nucleus, can exacerbate mood instability by affecting sleep-wake cycles, further amplifying the manic state through sleep deprivation and altered hormonal regulation.

• Key complication: Persistent mania can cause significant functional impairment, increasing risks of self-harm due to impulsivity and poor judgment, thereby necessitating timely clinical intervention to prevent long-term psychosocial consequences.

Patient Profile

Demographics:

35-year-old male, software engineer

History:

• Key past medical history: Bipolar disorder diagnosed 5 years ago

• Current medications: Lithium 900 mg/day, Aripiprazole 10 mg/day

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased energy and decreased need for sleep over the past two weeks

• Key symptoms: Elevated mood, pressured speech, racing thoughts, distractibility, engagement in high-risk activities (excessive spending), irritability

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 98%

Section 1

As the clinical team continues to monitor the patient, his manic symptoms have escalated, prompting further assessment. During a routine evaluation, the patient exhibits increased psychomotor agitation and continues to demonstrate pressured speech. His thought processes are notably disorganized, with frequent tangentiality making it challenging to maintain a coherent conversation. The nursing team observes that his irritability has intensified, occasionally leading to verbal altercations with staff and other patients. Despite efforts to engage him in structured activities, he remains highly distractible and exhibits little insight into his current condition, often denying the need for continued hospitalization.

In light of these developments, the medical team orders a series of diagnostic tests to assess the patient's therapeutic lithium levels and evaluate any potential metabolic disturbances. The results reveal a subtherapeutic lithium level of 0.5 mEq/L, which may account for the exacerbation of manic symptoms. Additionally, a complete blood count and metabolic panel are conducted, revealing a slight elevation in white blood cell count at 11,500/mm³ and mild hyponatremia with a sodium level of 133 mEq/L. These findings suggest the potential for dehydration, likely stemming from increased physical activity and inadequate fluid intake during this manic episode.

In response to these findings, the clinical team decides to adjust the patient's medication regimen, increasing the lithium dosage to achieve therapeutic levels, while closely monitoring for signs of lithium toxicity. The team also emphasizes the importance of maintaining proper hydration, implementing a fluid intake schedule to mitigate the risk of further electrolyte imbalance. This adjusted management plan aims to stabilize the patient's mood and reduce the risk of complications associated with persistent mania. The nursing staff continues to provide structured support and education, focusing on medication adherence and lifestyle modifications to enhance long-term stability.

Section 2

As the clinical team implements the adjusted management plan, initial assessments following the medication change reveal subtle yet promising improvements in the patient's condition. Vital signs indicate a stable blood pressure of 120/80 mmHg, heart rate of 78 bpm, and respiratory rate of 18 breaths per minute, suggesting physiological stability. However, the patient remains slightly agitated and continues to exhibit pressured speech, though with reduced intensity compared to previous observations. Notably, the patient's sleep patterns show slight improvement, with reports of approximately 4-5 hours of rest per night, a positive change from his earlier state of insomnia.

Despite these advancements, the patient continues to exhibit poor insight into his condition and insists on his ability to manage without hospitalization. During interactions, he occasionally demonstrates grandiose delusions, claiming he has important tasks to complete that only he can accomplish. His level of distractibility remains high, making it challenging for the nursing team to engage him in prolonged therapeutic conversations. To address these ongoing symptoms, the nursing staff increases their focus on psychoeducation, emphasizing the importance of medication adherence and the risks associated with untreated mania.

Laboratory monitoring following the lithium dosage adjustment indicates a gradual improvement in serum lithium levels, now at 0.7 mEq/L, moving towards the therapeutic range. However, repeat electrolyte panels reveal persistent mild hyponatremia, with sodium levels slightly increasing to 134 mEq/L. This finding, coupled with the patient's ongoing high activity levels, necessitates continued emphasis on adequate hydration. The team continues to monitor for any signs of lithium toxicity, such as tremors or gastrointestinal disturbances, which have yet to manifest. These efforts aim to further stabilize the patient's mood and prevent potential complications, setting the stage for a more comprehensive recovery plan.

Section 3

In the following days, the clinical team observes a notable change in the patient's status. While his vital signs remain stable, with a blood pressure of 118/76 mmHg, heart rate of 75 bpm, and respiratory rate of 17 breaths per minute, the patient begins to exhibit new symptoms that raise concerns. During a routine check, the nursing staff notices the onset of fine hand tremors, which prompt an immediate review of his medication regimen and serum lithium levels. A subsequent lithium level test reveals an increase to 0.9 mEq/L, which, although still within therapeutic range, suggests that the patient might be exhibiting early signs of lithium sensitivity. This development requires careful titration of his medication dosage to avoid progression to toxicity.

Simultaneously, the patient reports an increase in thirst and frequent urination, leading the team to suspect possible lithium-induced diabetes insipidus. To address this, the nursing staff educates the patient about the importance of maintaining hydration while monitoring fluid intake more rigorously. Electrolyte panels reveal a slight further drop in sodium levels to 132 mEq/L, intensifying the need for fluid and electrolyte management. This combination of symptoms necessitates a collaborative discussion among the healthcare team to reassess the risk-benefit ratio of continuing lithium therapy at the current dosage, considering potential adjustments to ensure patient safety and comfort.

In light of these new complications, the multidisciplinary team convenes to refine the management plan, incorporating additional strategies to mitigate the side effects while maintaining therapeutic efficacy. They discuss the potential introduction of adjunctive medications to stabilize mood without exacerbating current side effects. The team also reinforces psychoeducation with the patient and his family to enhance understanding of these new symptoms and the importance of vigilant monitoring. These efforts aim to stabilize the patient's condition, ensuring a safer trajectory towards recovery while preventing further complications.

Section 4

A week after the adjustments to the medication regimen and the increased focus on fluid management, the clinical team observes another change in the patient's status. The patient begins to show signs of cognitive slowing and mild confusion, particularly evident during conversations and routine assessments. His speech becomes slightly disorganized, and he struggles with tasks that require concentration, such as simple arithmetic exercises. Although his vital signs remain stable, with a blood pressure of 116/74 mmHg, heart rate of 72 bpm, and respiratory rate of 18 breaths per minute, these cognitive changes raise concerns about the potential progression of lithium-related side effects.

The healthcare team orders a comprehensive metabolic panel and a repeat lithium level test to further investigate these cognitive symptoms. The results indicate a lithium level of 1.0 mEq/L, which is at the upper threshold of the therapeutic range, along with a sodium level now at 130 mEq/L. These findings suggest an increased risk of lithium toxicity, necessitating a reevaluation of his medication plan. Additionally, the patient's serum creatinine is noted to be elevated at 1.5 mg/dL, suggesting a potential impact on renal function, which could be contributing to the altered mental status.

In response to these developments, the team decides to lower the lithium dosage and introduce a low-dose atypical antipsychotic to help stabilize the patient's mood without exacerbating his current side effects. The nursing staff intensifies their monitoring efforts, focusing on hydration status and signs of worsening confusion or renal impairment. Through ongoing patient and family education, the team emphasizes the importance of reporting any further changes in mental status or other concerning symptoms promptly. These measures aim to address the immediate risks while maintaining a trajectory towards stabilization, creating a foundation for further adjustments as the patient's condition evolves.

Section 5

As the team implements the adjusted medication regimen, including the reduced lithium dose and the introduction of a low-dose atypical antipsychotic, they closely monitor the patient's response. Over the next several days, the patient shows some improvement in cognitive function; his speech becomes more organized, and he is better able to engage in conversations. However, the nursing staff notices that he is experiencing increased thirst and frequent urination, raising concerns about potential diabetes insipidus, a known complication of lithium therapy. His vital signs remain stable with a blood pressure of 114/76 mmHg, heart rate of 70 bpm, and respiratory rate of 16 breaths per minute. However, the patient's sodium level has decreased further to 128 mEq/L, and his urine output is significantly elevated.

In light of these findings, the healthcare team orders a water deprivation test to assess the patient's ability to concentrate urine, suspecting nephrogenic diabetes insipidus. The test reveals that the patient is unable to adequately concentrate urine even with water restriction, confirming the diagnosis. This complication demands a revision of the current management plan. The team decides to initiate treatment with a thiazide diuretic and amiloride, aiming to reduce urine output and manage the electrolyte imbalance. These medications are carefully chosen to avoid exacerbating the lithium-induced renal effects while addressing the diabetes insipidus.

The nursing team continues to educate the patient and his family about the importance of maintaining adequate hydration and monitoring for any further changes in mental status or physical symptoms. They also provide guidance on recognizing signs of electrolyte imbalance and reinforce the need for regular follow-up appointments to monitor the patient's renal function and overall health. As the team implements these new interventions, they remain vigilant for any emerging complications, ready to adjust the treatment plan as necessary to ensure the patient's safety and well-being.